Expansion Of Drug Development Pipeline
Filed with ASX · · 3 pages · English
PYC Therapeutics Limited on 6ix
Earlier from PYC Therapeutics
- Appendix 4C - quarterly
- Quarterly Shareholder Update
- Drug Delivery Greater Than 100% More Effective In Animals
- Conclusion of Genentech Antimicrobial Collaboration
- Retail Offer Document
Later from PYC Therapeutics
- CEO Appointment and Establishment of US Office
- Investor Presentation - February 2020
- Successful Efficacy Result on Path to First in Human Studies
- March 2020 Quarterly Activities and Cash Flow Report
- S&P DJI Announces June 2020 Quarterly Rebalance
Follow PYC Therapeutics into a list and get an email when it puts out news.
Follow PYC Therapeutics